A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Page 1 of 2 12 LastLast
Results 1 to 10 of 11

Thread: Lung cancer research in news

  1. #1

    Lung cancer research in news

    Article about OTS964 at Univ. of Chicago. Early mouse study.
    TOPK inhibitor. TOPK ( T–lymphokine-activated killer cell– originated protein kinase ) .
    http://www.sciencedaily.com/releases...1022143559.htm

    The Japanese company involved:
    http://www.oncotherapy.co.jp/en/rese...ent-pipelines/
    Last edited by lancepeace; 08-04-2016 at 01:04 PM. Reason: add details
    DOB Sept. 1947. Prostate cancer Gleason 7 (3+4), PSA 5 in Oct 2010. Cryoablation Jan. 2011. Had some complications.
    Experienced nocturia, irritable bladder summer 2011. "Agent Orange"compensation from VA Oct 2011.
    PSA: .05 01/26/2012, .06 6/26/2012, .04 12/24/2012, .04 6/26/13, .05 1/27/14, .05 10/21/14, .04 10/15
    I am eating vegan mostly plus a little fish. Take some supplements.
    (Any advice given is the personal opinion of a layman and is not intended to replace the advice of a health professional.)

  2. #2

    Small molecule Bax agonists

    Small molecule Bax agonists. Univ. of Texas & Emory study.

    http://www.sciencedaily.com/releases...1023092033.htm

  3. #3

    Another Bax study


  4. #4
    Administrator Top User lisa1962's Avatar
    Join Date
    Jan 2013
    Posts
    3,889
    Very interesting indeed. Thank you for posting this. Sounds promising.

  5. #5

    TRAIL and CDK9 inhibitor

    http://www.sciencedaily.com/releases...1030213717.htm

    Lisa, I hope one of the new technologies pans out.
    Early study in UK of two drugs that may encourage cancer cell death. TRAIL and CDK9 inhibitor ( SNS-032 ) . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Last edited by lancepeace; 11-04-2014 at 03:49 PM.

  6. #6

    Article on senescence

    http://www.sciencedaily.com/releases...0302123335.htm

    An approved drug, iloprost ,makes cells dormant mimicking Wnt7a pathway.

  7. #7
    Study suggests that statin cholesterol medication may have a benefit in lung cancer. Statins may lower inflammation in addition to cholesterol.

    http://www.sciencedaily.com/releases...0501081836.htm

  8. #8

    ASCO presentations August 2016 for lung cancer

    http://journals.lww.com/oncology-tim..._Cancer.5.aspx

    ASCO lung cancer presentations August 2016
    DOB Sept. 1947. Prostate cancer Gleason 7 (3+4), PSA 5 in Oct 2010. Cryoablation Jan. 2011. Had some complications.
    Experienced nocturia, irritable bladder summer 2011. "Agent Orange"compensation from VA Oct 2011.
    PSA: .05 01/26/2012, .06 6/26/2012, .04 12/24/2012, .04 6/26/13, .05 1/27/14, .05 10/21/14, .04 10/15
    I am eating vegan mostly plus a little fish. Take some supplements.
    (Any advice given is the personal opinion of a layman and is not intended to replace the advice of a health professional.)

  9. #9
    Moderator Top User jorola's Avatar
    Join Date
    May 2014
    Posts
    1,711
    Thank you for all that you do here in keeping us update on this research!
    Wife to husband with squamous lung cancer stage 3 b
    dx - April 20/14
    tx started May 20/14 - radiation and chemo
    June 23 - chemo finished
    June 24 - tumor 1/3 the original size
    July 4 - radiation finished
    July 8 - PET scan shows tumor almost gone, lymph nodes back to normal
    Married July 19/14
    Sept 9/14 - repeat can shows tumor continues to shrink more, no new spots. New coughing and pain due to chest infection or side effect of radiation.
    Sept 19/14 - not infection but pneumonitis, place on dex for 4 weeks
    Oct 22/14 - now off of dex and facing even more symptoms of withdrawal
    Dec 16/14 - pretty much nothing left but a scar
    April 7/15 - ditto scan and screw you stats
    Oct 6/15 - more scarring but still cancer still gone
    Feb 2016 -scan the same
    Aug 2016 - more of the same
    Aug 2017 - and ditto
    Aug 2018 - 4 yrs NED

  10. #10

    Opdivo immunotherapy appears to fail first line NSCLC Phase 3 trial

    You are welcome, Jorola.

    In the link below, Opdiva fails first line NSCLC monotherapy trial, but continues in combination trials such as with Yervoy.

    http://www.fiercebiotech.com/biotech...rst-line-nsclc

    http://nyti.ms/2b8Hocb
    Last edited by lancepeace; 08-05-2016 at 06:41 PM. Reason: Add article

 

Similar Threads

  1. Master Protocol for Lung Cancer research
    By franniedid in forum Lung Cancer Forum
    Replies: 0
    Last Post: 06-20-2013, 01:36 PM
  2. Good news on the research front
    By joepet in forum Cancer News
    Replies: 0
    Last Post: 04-14-2010, 11:49 AM
  3. Research Reveals What Drives Lung Cancer's Spread
    By brainman in forum Lung Cancer Forum
    Replies: 0
    Last Post: 07-03-2009, 10:22 PM
  4. Replies: 0
    Last Post: 04-13-2005, 04:40 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •